Restless Legs Syndrome: Which Nutrients Actually Have Evidence

If your legs start crawling or tingling the moment you sit down at night, you have probably landed on a flat list of six vitamins with no explanation of which one has real evidence behind it. This article grades the nutrients by how strong the evidence actually is, names the numbers a clinician uses, and tells you what to ask your doctor to test before you spend money. The short version: iron status is the one nutrient question with deep, replicated evidence in restless legs syndrome, iron is a cofactor in normal dopamine synthesis, and iron is the one supplement you must not start without a blood test first.

What Restless Legs Syndrome Actually Is

Restless legs syndrome is a neurological condition diagnosed from your history, not from a scan or a single lab value. An international consensus group, the International Restless Legs Syndrome Study Group, defined four essential features that all have to be present [17].

1. An urge to move the legs, usually with uncomfortable or unpleasant sensations in them.
2. Rest makes it worse. The urge and the sensations begin or intensify when you are lying down or sitting still.
3. Movement brings relief. Walking or stretching eases it, at least for as long as you keep moving.
4. Evening and night are worse. Symptoms are worse in the evening or night than during the day, or they only show up then.

That fourth feature is why the condition is described as a sleep problem rather than a leg problem. The sensations are the symptom, and the timing is what makes it disruptive.

How common it is, and why the numbers vary

Published prevalence figures range widely, and most of that spread comes from how strictly the definition is applied.

A synthesis of the epidemiology literature puts the range at 9.4% to 15% for any RLS symptoms, 3.9% to 14.3% when the IRLSSG minimal criteria are required, and 2.2% to 7.9% when symptom frequency and severity are added [20]. The strictest definition describes a much smaller group than the loosest one. Two large studies show what that looks like in practice: the REST general population study interviewed 16,202 adults and focused on medically significant RLS, meaning symptoms at least twice a week with moderate distress [18], and a separate European survey covered 18,980 subjects across five countries [19].

RLS is common enough that you are not unusual for having it, and specific enough that the exact percentage depends entirely on how the question is asked [20].

What RLS is often confused with

Those four features exist because RLS is easy to mix up with other things. Leg cramps, neuropathy, and arthritis all produce nighttime leg discomfort.

The detail that separates them is the urge to move. Cramps hurt and then stop, and neuropathy tends to be constant, often affecting the feet in a numb or burning way. RLS makes you want to move, and moving helps, which is the pattern a clinician listens for.

Why Restless Legs Syndrome Gets Worse at Night

Almost everyone with RLS notices the same daily shape: manageable in the morning, worse in the evening, worst when trying to fall asleep. That pattern is written into the diagnostic criteria, which makes it a core feature of the condition rather than a byproduct of when you happen to be resting [17].

Researchers do not have a complete explanation for the timing. Two systems are involved, and both run on daily rhythms: iron handling in the brain and dopamine signaling [7][8].

The iron deficit in RLS appears to begin at the blood-brain interface, so the problem sits in how iron gets delivered into the brain rather than simply in how much iron is in your blood [4]. Dopamine signaling depends on iron as a cofactor [8]. The leading explanation is that a system already short on a key raw material has less room to absorb the normal daily variation in dopamine activity. That is a working hypothesis, not a settled finding.

What is not in doubt is the downstream cost. In a primary care study that screened 23,052 patients, 9.6% reported weekly RLS symptoms, and 88.4% of those with RLS reported at least one sleep-related symptom [21].

The nighttime pattern is the reason RLS is a sleep problem, which is why it is worth taking seriously even when the sensations themselves are mild.

The Iron Story: The Strongest Evidence in This Topic

If you only remember one section of this article, make it this one. Iron is where the evidence is deepest, and also where the popular articles are vaguest.

The first clue came from blood tests

Two early studies noticed that people with RLS tended to have lower iron stores than people without it.

• A study of 27 patients found that serum ferritin, the protein that stores iron, correlated inversely with RLS symptom severity. Lower ferritin went with worse symptoms [5].
• A study in older adults found reduced serum ferritin in RLS (median 33 versus 59 µg/L, p<0.01), an inverse correlation between ferritin and severity (rho -0.53, p<0.05), and improvement in severity in 15 patients given ferrous sulphate for two months [6].

That second study is from 1994, it was small, and it had no placebo group. It pointed the way rather than proving the case.

Then the imaging and tissue evidence arrived

What turned a correlation into a mechanism was a set of studies using four different methods.

• Imaging: an MRI study found reduced brain iron in the substantia nigra in people with RLS, proportional to symptom severity. It included 5 people with RLS and 5 controls [1].
• Autopsy tissue: iron and H-ferritin staining were markedly decreased in the substantia nigra of RLS brains, comparing 7 RLS brains against 5 controls [2].
• Cerebrospinal fluid: ferritin in the fluid surrounding the brain and spinal cord was lower in RLS (1.11 ± 0.25 versus 3.50 ± 0.55 ng/mL, p=0.0002) [3].
• Where the problem starts: a later post-mortem study with 18 controls and 14 RLS cases concluded that the brain iron deficit originates at the blood-brain interface, meaning the delivery system rather than total body iron [4].

Every one of these studies is small. What makes the case strong is not any single result, but that four independent methods, imaging, autopsy tissue, spinal fluid, and blood correlation, all point the same direction [1][2][3][5].

Iron is the only nutrient in this article where the evidence spans imaging, autopsy, cerebrospinal fluid, and randomized trials.

Brain iron and blood iron are not the same thing

This is the single most useful fact on the topic, and most articles skip it entirely. The cerebrospinal fluid study measured ferritin in the fluid around the brain and compared it to ferritin in the blood of the same people.

CSF ferritin was roughly a third as high in the RLS group, while serum ferritin showed no difference between the groups at all [3]. You can have an unremarkable iron panel and still have a brain that is short on iron [3][4].

A normal blood iron result does not rule out an iron problem in the brain. It only tells you the blood side is fine.

What the ferritin numbers mean

Ferritin is the standard way to estimate your iron reserves. In RLS, the thresholds clinicians work with are higher than the thresholds used to define ordinary anemia.

The 2025 American Academy of Sleep Medicine guideline is the current reference point for treatment decisions, and the tiers discussed around it look like this:

• Below 75 ng/mL: iron therapy is generally considered, even when hemoglobin is normal.
• 75 to 100 ng/mL: a gray zone where intravenous iron may still be considered for some patients.
• Below 200 ng/mL in kidney disease: a higher threshold is applied in people with kidney failure.

Those tiers come from guideline consensus rather than one definitive trial, so treat them as the framework your clinician works inside rather than a line you apply yourself [12]. The randomized trials used tighter cutoffs: the largest intravenous iron trial enrolled only patients with ferritin at or below 45 µg/L [10].

Oral iron versus intravenous iron

The evidence here is more mixed, and it is worth reading carefully.

• Oral iron: the 1994 study gave 15 patients ferrous sulphate for two months and severity improved [6]. Small, old, and uncontrolled.
• Intravenous iron, one trial: a randomized, double-blind, placebo-controlled trial of intravenous iron sucrose raised cerebrospinal fluid ferritin and reduced RLS severity at two weeks. It was an interim analysis with 7 people on placebo and 11 on iron [9].
• Intravenous iron, a larger trial: 60 patients with ferritin at or below 45 µg/L were randomized. Median severity scores fell from 24 to 7 with iron versus 26 to 17 with placebo at week 11, and that difference was not statistically significant (p=0.123). At week 7 the scores were 12 versus 20 (p=0.017). Dropouts for lack of efficacy were 19 of 31 on placebo versus 5 of 29 on iron [10].
• Intravenous iron in dialysis: a trial of iron dextran 1000 mg reduced RLS symptoms in people with end-stage renal disease. This was a dialysis population, not a general one [11].

So the larger trial missed its primary endpoint, hit a signal at an earlier timepoint, and saw far more placebo patients quit for lack of benefit [10]. That is a real but imperfect result, and it is why clinical guidance treats iron therapy as a medical decision rather than a supplement decision.

The 2016 American Academy of Neurology guideline rated intravenous ferric carboxymaltose as having moderate evidence (Level B) [13]. Note what that rating covers: intravenous iron given in a clinical setting, which is not the same thing as a bottle of iron tablets.

The clinical evidence is best read as proof that iron status matters, not as instructions for self-treatment [12][13].

If your clinician does recommend oral iron, two practical points help. Absorption is better on an empty stomach, and vitamin C helps your body take up non-heme iron from food and supplements. Forms also differ in how gentle they are on the stomach, so ask about the form, not just the dose, and see our guide to how iron supplements differ.

The warning that is not optional

Do not start an iron supplement because you think you have restless legs syndrome. Get a ferritin test first.

Iron is not a nutrient where more is automatically safer. Three risks make self-treatment a bad idea:

• Iron overload. Your body has a limited ability to get rid of excess iron, and it accumulates in the liver, heart, and pancreas. In people with hemochromatosis, a common inherited condition, routine supplementation can cause real harm.
• Masking another problem. Iron can improve a blood count that was actually pointing at bleeding in the gut or another serious cause. Correcting the number can hide the reason behind it.
• The wrong target. If your ferritin is normal, extra oral iron may not reach the brain iron pool, and you will still get the gastrointestinal side effects.

Ask your clinician for a ferritin test. If they prescribe iron, take it as prescribed, and re-test rather than guessing.

Iron Is a Cofactor for Dopamine

This mechanism explains why the same nutrient keeps appearing in both the blood research and the brain research.

Dopamine is built in two steps, and the first step is the slow one. The enzyme that runs that step, tyrosine hydroxylase, needs iron to function. Iron is not a side note in dopamine production. It is a cofactor for the rate-limiting enzyme, which means low iron availability puts a ceiling on how much dopamine the system can make [8].

The leading model of RLS describes two problems running together: altered dopamine signaling and brain iron insufficiency [7]. A later review reached the same conclusion, listing both brain iron insufficiency and altered dopaminergic function as implicated [8]. A narrative review on iron, folate, and RLS describes iron the same way, as a cofactor in dopamine production [27], though it appeared in a non-indexed journal, so read it for framing rather than as primary evidence.

For the wider picture of nutrients that support normal brain function, Agape's Brain & Memory reference covers that ground.

The genetic piece

Common genetic variants are the strongest known risk factors for RLS. The most consistently replicated signals sit near genes involved in brain development and iron regulation, including BTBD9 and MEIS1 [8]. Those variants are common in the general population, so carrying them raises risk without deciding your outcome.

Augmentation: why dopamine drugs moved down the list

For years, dopamine agonists were the first-line drug treatment for RLS. In the 2016 American Academy of Neurology guideline, pramipexole, rotigotine, and cabergoline all carry strong (Level A) evidence for short-term benefit [13].

The problem shows up over time, and it has a name. Augmentation means the medication itself makes the underlying condition worse: symptoms start arriving earlier in the day, spread from the legs to the arms or trunk, and intensify at the same dose [13].

Augmentation is why dopamine agonists are no longer the automatic first choice. The 2016 guideline flagged the risk while still rating those drugs highly for short-term use [13], and the 2025 American Academy of Sleep Medicine guideline is the more current statement on how these therapies are positioned [12].

What that means here is simple. The dopamine system is central to RLS, but more dopamine signaling is not a simple fix. Keep that in mind when you read a supplement marketed as a dopamine solution for restless legs.

Magnesium for Restless Legs: Real but Modest Evidence

Magnesium is the nutrient people ask about most, and it is where the gap between reputation and evidence is widest. Here is the full body of human evidence, graded.

• One small open-label pilot. Ten people took oral magnesium in the evening for four to six weeks. Periodic leg movements with arousals fell from 17 ± 7 to 7 ± 7 events per hour (p<0.05) [14]. The study was open-label with no placebo group, so expectation alone cannot be ruled out.
• One systematic review. A 2019 review of magnesium for RLS concluded the evidence base is small and weak, and identified only one randomized placebo-controlled trial, which found no significant benefit for magnesium and may have been underpowered [15]. That trial predates the one described below, so the two are separate studies.
• One randomized trial. A single-blind trial with 75 participants in three arms compared magnesium 250 mg as magnesium oxide, vitamin B6 40 mg, and placebo daily. Both active groups improved in severity and sleep quality over two months [16]. Single-blind means participants knew their group, which matters for a symptom measured by how you feel.

The overall picture is that magnesium has a small amount of real human evidence, not a strong one. It is worth discussing with your clinician, and it is not a proven treatment.

Two practical notes. Magnesium supplements commonly cause loose stools, and people with kidney disease need clinical guidance because the kidneys regulate how much stays in the body. If you do decide to try it, the form matters: our breakdown of the types of magnesium supplements explains which forms are absorbed better and which are gentler on digestion.

The Other Nutrients People Ask About

Vitamin D, vitamin B12, and folate all show up on lists for RLS. Each has a real thread of research behind it. None has the depth of the iron evidence, and it is worth saying so plainly.

Vitamin D

The association between low vitamin D and RLS is consistent and repeated.

• A population-based case-control study compared 78 RLS patients with 123 controls. Vitamin D deficiency was present in 75.6% of the RLS group versus 42.3% of controls (p<.001), and the odds of RLS at a vitamin D level below 50 nmol/L were 4.24 times higher [24].
• A separate study of 155 consecutive patients found a similar association [23].

Now the treatment side, which is the more useful half. An early uncontrolled study followed 12 adults with primary RLS and vitamin D deficiency, and severity improved after the deficiency was corrected [22]. Twelve people, no control group, so that result cannot carry much weight by itself.

The randomized follow-up from the same research group is the one that matters. Thirty-five adults with RLS were assigned to weekly vitamin D or placebo for 12 weeks. Symptom severity did not improve in the vitamin D group compared with placebo [29].

Low vitamin D is common in people with RLS. But when it has been tested properly, correcting it has not corrected the symptoms [29].

There is also a plausible reverse explanation. RLS disrupts sleep, and disrupted sleep often means less time outdoors in daylight, so low vitamin D may be a consequence of the condition as much as a contributor to it.

Vitamin B12

A case-control study compared 80 RLS patients with 80 matched controls. Serum B12 was significantly lower in the RLS group, B12 was independently associated with RLS (OR 0.97, 95% CI 0.96 to 0.98), and B12 was negatively correlated with symptom severity [28].

That is a consistent association from a reasonably sized study. What it is not is treatment evidence, because no trial gave people B12 and measured whether symptoms changed [28]. A case-control design also cannot tell you which direction the relationship runs.

B12 is still worth testing on its own merits, since B12 deficiency is a genuinely treatable cause of nerve symptoms and it is easy to miss. B12 and folate also sit at the center of methylation, the chemistry your body uses to activate and clear many nutrients. Agape's Detox & Methylation reference covers that side of the story.

Folate

Folate's link to RLS comes mainly from pregnancy research, and the evidence is old and thin.

• An early 1977 report linked folate deficiency to RLS in pregnancy. It was published as a letter, a weak form of evidence by modern standards [25].
• A pregnancy study found RLS prevalence rose from 0 before conception to 23% in the third trimester, and the women with restless legs had lower folate and iron status [26].

Pregnancy RLS is common, it usually improves after delivery, and the folate and iron findings are associations rather than proof of cause [26].

Vitamin E, and why it is not on this list

Vitamin E appears on most vitamin lists for RLS. We left it out, and the reason is the evidence itself. The human data behind it comes from small studies in dialysis patients, a group whose RLS has its own distinct drivers. That does not generalize to the general population, and it does not support a recommendation.

What Makes Restless Legs Worse

Some of the most useful information on this topic has nothing to do with supplements. Several everyday factors and common medications are reported to aggravate symptoms.

Worth reviewing with a clinician or pharmacist:

• Sedating antihistamines. Diphenhydramine and similar sleep-aid antihistamines are commonly reported to worsen RLS symptoms. If you use one as a sleep aid and your legs got worse, that timing is worth mentioning.
• Antidepressants. SSRI and SNRI antidepressants are associated with triggering or worsening RLS symptoms in some people.
• Iron-depleting medications. Proton pump inhibitors and antacids reduce how much iron you absorb from food and supplements.
• Blood donation. Regular donation draws down your iron stores, so if you donate often and have RLS, your ferritin is worth checking.
• Alcohol. Commonly reported as a trigger for evening symptoms.
• Caffeine. The research is not consistent enough for a firm answer, so the honest approach is a personal trial.
• Long stretches of sitting still. Not a cause, but it is the situation the condition feeds on.

None of this is a reason to stop a prescribed medication on your own. Bring the list to your prescriber or pharmacist and ask for a medication review. That conversation is free, and it is often more useful than any supplement.

How to Test for Restless Legs Syndrome

RLS itself is diagnosed from your history, using the four features above. Testing is not how you confirm RLS. Testing is how you find a treatable contributor, and the main one to look for is iron status.

The test that matters most is ferritin. It estimates your iron reserves, and it is the number the RLS thresholds are built around [12].

Five things to get right when you and your clinician arrange it:

1. Ask for ferritin specifically. A standard blood count can look completely normal while ferritin is low, and ferritin is the number that guides iron decisions in RLS [3][12].
2. Ask for a morning, fasting draw. Ferritin and iron levels fluctuate through the day and shift with what you have eaten, so testing at a consistent time makes the result easier to interpret.
3. Wash out supplements for 24 hours before the draw, with your clinician's agreement. A recent iron dose can skew an iron panel. If you are on prescribed iron, do not stop it on your own, just ask.
4. Ask about transferrin saturation alongside ferritin. It shows how much iron is actually circulating and available, which adds context ferritin alone does not give you.
5. Ask what else is worth ruling out. Kidney function, vitamin B12, folate, and vitamin D are all reasonable additions given the associations described above [22][24][26][28].

The single most valuable sentence you can say to your doctor is: "I have restless legs symptoms and I would like my ferritin checked." That is a specific, testable, non-supplement request, and it is the one this entire topic turns on.

When to See a Doctor

RLS is a diagnosed condition, and diagnosis is the first step, not the last.

First, because the mimics are common. Leg cramps, neuropathy, and arthritis can all look like RLS at 2 a.m. A clinician can tell them apart from your history, and the answer changes what helps.

Second, because RLS can be a signal of something else worth finding. RLS is more commonly reported in certain situations, including pregnancy, kidney disease, and iron deficiency anemia [12]. If any of those apply to you, testing matters more, not less. Agape's Specialty Support reference covers nutritional considerations for a range of individual situations.

Book an appointment if any of the following apply:

• Symptoms interrupt your sleep most nights, or you are sleepy during the day.
• Symptoms have started spreading to your arms or trunk.
• Symptoms appeared suddenly, or began after you started a new medication.
• Your legs bother you during the day as well as at night.
• You are pregnant, you have kidney disease, or you have been told you are anemic.
• You have been considering iron on your own. This is the appointment that should come first.

One closing note on what supplements can and cannot do here. A nutrient can support normal iron status, and iron is a cofactor in normal dopamine synthesis. No supplement is a substitute for a diagnosis, a ferritin test, or a conversation with your clinician about what is actually driving your symptoms.

References

1. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263-265. PMID 11160969. https://pubmed.ncbi.nlm.nih.gov/11160969/
2. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304-309. PMID 12913188. https://pubmed.ncbi.nlm.nih.gov/12913188/
3. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698-1700. PMID 10762522. https://pubmed.ncbi.nlm.nih.gov/10762522/
4. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011;134(Pt 4):959-968. PMID 21398376. https://pubmed.ncbi.nlm.nih.gov/21398376/
5. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21(4):371-377. PMID 9646381. https://pubmed.ncbi.nlm.nih.gov/9646381/
6. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200-203. PMID 8085504. https://pubmed.ncbi.nlm.nih.gov/8085504/
7. Allen RP, Earley CJ. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5(4):385-391. PMID 15222997. https://pubmed.ncbi.nlm.nih.gov/15222997/
8. Dauvilliers Y, Winkelman JW. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease). Sleep Med. 2014;15(11):1288-1301. PMID 25201131. https://pubmed.ncbi.nlm.nih.gov/25201131/
9. Earley CJ, Horska A, Mohamed MA, Barker PB, Beard JL, Allen RP. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med. 2009;10(2):206-211. PMID 18280205. https://pubmed.ncbi.nlm.nih.gov/18280205/
10. Grote L, Leissner L, Hedner J, Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord. 2009;24(10):1445-1452. PMID 19489063. https://pubmed.ncbi.nlm.nih.gov/19489063/
11. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004;43(4):663-670. PMID 15042543. https://pubmed.ncbi.nlm.nih.gov/15042543/
12. Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025. PMID 39324694. https://pubmed.ncbi.nlm.nih.gov/39324694/
13. Winkelman JW, Armstrong MJ, Allen RP, et al. Practice guideline summary: Treatment of restless legs syndrome in adults (AAN). Neurology. 2016;87(24):2585-2593. PMID 27856776. https://pubmed.ncbi.nlm.nih.gov/27856776/
14. Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep. 1998;21(5):501-505. PMID 9703590. https://pubmed.ncbi.nlm.nih.gov/9703590/
15. Marshall NS, Serinel Y, Killick R, et al. Magnesium supplementation for the treatment of restless legs syndrome and periodic limb movement disorder: a systematic review. Sleep Med Rev. 2019;48:101218. PMID 31678660. https://pubmed.ncbi.nlm.nih.gov/31678660/
16. Jadidi A, Rezaei Ashtiani A, Khanmohamadi Hezaveh A, et al. Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial. BMC Complement Med Ther. 2022;23(1):1. PMID 36587225. https://pubmed.ncbi.nlm.nih.gov/36587225/
17. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology (IRLSSG report). Sleep Med. 2003;4(2):101-119. PMID 14592341. https://pubmed.ncbi.nlm.nih.gov/14592341/
18. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. PMID 15956009. https://pubmed.ncbi.nlm.nih.gov/15956009/
19. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547-554. PMID 12127170. https://pubmed.ncbi.nlm.nih.gov/12127170/
20. Innes KE, Selfe TK, Agarwal P. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283-295. PMID 21795081. https://pubmed.ncbi.nlm.nih.gov/21795081/
21. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST primary care study. Sleep Med. 2004;5(3):237-246. PMID 15165529. https://pubmed.ncbi.nlm.nih.gov/15165529/
22. Wali SO, Abaalkhail B, Alhejaili F, Pandi-Perumal SR. The effect of vitamin D supplements on the severity of restless legs syndrome. Sleep Breath. 2015;19(2):579-583. PMID 25148866. https://pubmed.ncbi.nlm.nih.gov/25148866/
23. Cikrikcioglu MA, Haliloglu I, Serin E, et al. Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat. 2014;10:953-958. PMID 24899811. https://pubmed.ncbi.nlm.nih.gov/24899811/
24. Park KY, Seo S, Kwon JI, et al. The association between vitamin D level and restless legs syndrome: a population-based case-control study. J Clin Sleep Med. 2018;14(4):557-564. PMID 29609719. https://pubmed.ncbi.nlm.nih.gov/29609719/
25. Botez MI, Lambert B. Folate deficiency and restless-legs syndrome in pregnancy. N Engl J Med. 1977;297(12):670. PMID 895774. https://pubmed.ncbi.nlm.nih.gov/895774/
26. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med. 2001;10(4):335-341. PMID 11445024. https://pubmed.ncbi.nlm.nih.gov/11445024/
27. Patrick LR. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev. 2007;12(2):101-112. PMID 17604457. https://pubmed.ncbi.nlm.nih.gov/17604457/
28. Possible association between vitamin B12 deficiency and restless legs syndrome. Clin Neurol Neurosurg. 2022;223:107477. PMID 36401952. https://pubmed.ncbi.nlm.nih.gov/36401952/
29. Wali SO, Abaalkhail B, Alhejaili F, Pandi-Perumal SR. Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial. Sleep Breath. 2019;23(2):595-601. PMID 30430372. https://pubmed.ncbi.nlm.nih.gov/30430372/

What We Recommend

These are the products that supply the nutrients and forms discussed above. Nothing here replaces a ferritin test or a conversation with your clinician, and the iron option in particular is one to ask about rather than start on your own.

Frequently Asked Questions